Dr. Carlos López Jiménez

• 2025-Present – Medical Oncology Specialist, Sarcoma Unit. Hospital Universitario Fundación Jiménez Díaz, Madrid.
• 2024 – Clinical observership in Endocine and Neuroendocrine Oncology. Institut Gustave Roussy, Villejuif.
• 2019-2024 – Medical Oncology Resident. Hospital General Universitario Gregorio Marañón, Madrid.

Systemic treatment of sarcomas and other mesenchymal neoplasms; including various chemotherapy regimens, immunotherapy, targeted therapy, and their combinations.

Research:

• Prognostic molecular factors of relapse related to genotype and immunomodulation in localized gastrointestinal stromal tumor (GIST) – Asociación Española Contra el Cáncer.

Teaching:

• 2025-Present – Collaborating doctor in practical teaching. Facultad de Medicina. Universidad Alfonso X El Sabio.
• 2019-2024 – Collaborating doctor in practical teaching. Facultad de Medicina. Universidad Complutense de Madrid.

• Arregui M, Calles A, Galera MDM, Gutiérrez A, López-Jiménez C, Agra C, Fernández A, Gutiérrez N, Toro M, Álvarez R. Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor. Oncotarget. 2024 Oct 11;15:717-724. doi: 10.18632/oncotarget.28654. PMID: 39392364; PMCID: PMC11468407.
• López-Jiménez, C., Gutiérrez, A., Juliao Caamaño, D.S. et al. Impact of COVID-19 in the incidence of venous thromboembolism (VTE) and clinical outcomes in cancer patients: a cohort study. Clin Transl Oncol (2024). https://doi.org/10.1007/s12094-024-03635-w
• Muñoz AJ, de Toro M, Ortega L, López C, Gutiérrez A, Juliao DS, Arregui M, Lobato N, Echavarría I, Márquez-Rodas I, Martín M. Venous thromboembolism incidence in cancer patients with germline BRCA mutations. Clin Transl Oncol. 2022 Jan;24(1):154-158. doi: 10.1007/s12094-021-02678-7. Epub 2021 Aug 9. PMID: 34374030.
• Torres Pérez-Solero G, Mullor Delgado LA, López Jiménez C. 2021. Tumores neuroendocrinos y enfermedad tromboembólica. Oncology Thrombosis Risk. Esmon Publicidad, S.A.. 2021-27, pp.6-21. ISBN 978-84-19264-05-3.

• C. Santomá Saladich, C. López Jiménez, A. Martirena Llantada, G.J. Marquez, N. Hindi Muñiz, J. Martin-Broto. Impact of clinical and treatment factors on trabectedin toxicity in soft tissue sarcomas. ESMO Sarcoma and Rare Cancer Congress 2025.
• M. Benavente de Lucas, C. López Jiménez, A. Gutierrez Ortiz de La Tabla, M.A. Cañete Muñoz, M. Palma Gomez, C. Cobos Lama, G. Hernandez Torrado, N. Gutierrez Alonso, M. Arregui Valles, R.M. Álvarez Álvarez. Clinical presentation, management and outcomes of primary cardiac sarcomas: A retrospective study. ESMO Sarcoma and Rare Cancer Congress 2025.
• Gutiérrez Ortiz A, López Jiménez C, Gutiérrez Alonso N, Iglesias Beiroa A, Arregui Valles M, Agra A, Álvarez R. Desmoid tumors: Experience of a Spanish reference center. ESMO Congress 2024.
• Cavanagh Podeta MM, Arregui M, López Jiménez C, Álvarez R. Elderly patients with soft tissue sarcoma: Experience from a Spanish reference center. ESMO Sarcoma and Rare Cancer Congress 2024.
• Soto Alsar J, Jiménez Rodríguez R, Gutiérrez Alonso N, Bringas Beranek M, Martín Lozano R, López Jiménez C, et al. Clinical characteristics and survival analysis in patients with isolated pulmonary metastases from colorectal cancer (CRC). ASCO Gastrointestinal Cancers Symposium 2024.
• López Jiménez C, Arregui Valles M, Juliao Caamaño DS, Gutiérrez A, Rodríguez Torres L, Calles Blanco A, Simón Adiego C, González Casaurrán G, Álvarez Álvarez R. P517 Pulmonary metastasectomy for sarcoma: a single-institution experience. Conective Tissue Oncology Society 2023 Annual Meeting.
• López Jiménez C, Martín Lozano R, Jiménez Rodríguez R, González Caraballo I, Benavente de Lucas M, Gutiérrez Ortiz A, et al. 2044P Bloodstream infections (BSI) in cancer patients: Epidemiology, antibiotic therapy and risk factors related to mortality. Annals of Oncology. 2023 Oct 1;34:S1083. ESMO Congress 2023.
• Arregui Valles A, López Jiménez C, Gutiérrez Ortiz A, Gutiérrez Alonso N, Juliao Caamaño DS, Soto Alsar J, Bringas Beranek M, Galera López MDM, Álvarez RM. 82P - Clinical impact of systematic next generation sequencing in bone and soft-tissue sarcomas: Experience of a Spanish reference center. Annals of Oncology (2023) 8 (1suppl_3): 101026-101026. 10.1016/esmoop/esmoop101026. ESMO Sarcoma and Rare Cancer Congress 2023.
• Ortega Morán L, Soto Alsar J, Jiménez Rodríguez R, López Jiménez C, Gutiérrez Ortiz A, Juliao Caamaño DS, et al. 2146P Cancer-associated thrombosis clinic: Experience of the Medical Oncology Department of a hospital in Spain. Annals of Oncology. 2023 Oct 1;34:S1117–8. ESMO Congress 2023.
• Benavente M, Gutierrez Alonso N, Bringas Beranek M, Soto Alsar J, Palma M, Cañete Muñoz MA, López Jiménez C, et al. 1648P Association between circulating tumor cell count and thrombosis in pancreatic cancer. Annals of Oncology. 2023 Oct 1;34:S909. ESMO Congress 2023.

• 2024 – "Fundación Mari Paz Jiménez Casado" Grant for Master’s in Musculoskeletal Tumors (Universidad Europea de Madrid, Grupo Español de Investigación en Sarcomas).
• 2021 – Excellence Grant for Master’s in Molecular Oncology (Universidad Rey Juan Carlos, Centro de Estudios Biosanitarios).
• 2019 – Extraordinary End-of-Degree Award (Universidad de Córdoba).
• 2019 – Caja Rural del Sur Award for the Best Academic Record in the Degree in Medicine.